跳至主要内容
临床试验/NCT03448640
NCT03448640已完成不适用

Efficiency and Safety of Phenylephrine and Tropicamide Used in Premature Retinopathy

Bulent Ecevit University0 个研究点目标入组 60 人开始时间: 2016年1月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
主要终点
The mean pupillary diameter

研究概览

简要总结

Because of the neonatologists reported that some infants had suffered from vomiting, bradycardia, hypotonia, and aspiration risk about 30-60 minutes after the fundus examination in the intensive care unit. The investigators observed the pupil dilation effects and side effects of tipple instillation of phenylephrine 2.5% plus tropicamide 0.5% ophthalmic drop combination which the investigators routinely used in ROP examination.

详细描述

Purpose: To determine effect and vital change after topical application of phenylephrine 2.5% and tropicamide 0.5% three times for retinopathy of prematurity (ROP) examination in preterm infants.

Methods: Pupillary diameter, blood pressure, pulse rate, and oxygen saturation were monitored before, and after up to 24 hours 60 ROP screening examinations.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
32 Weeks 至 34 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Infants who were first ROP examinations
  • infants born before 32 weeks.

排除标准

  • Developmental ocular and/or systemic anomalies.
  • Drug use that can affect vital values
  • Unstable general condition
  • Food intolerance
  • Recurrent vomiting.

结局指标

主要结局

The mean pupillary diameter

时间窗: an average of 1 year

will be measured with a ruler after 60 minutes instillation of mydriatic

次要结局

未报告次要终点

研究者

发起方
Bulent Ecevit University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Atilla Alpay

Asociate Pofessor Atilla Alpay

Bulent Ecevit University

相似试验